| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 09/22/2004 | EP1458373A1 Use of lipoxin analogs to promote cell defense against gram-negative infections |
| 09/22/2004 | EP1458368A1 Use of norepinephrine reuptake inhibitors for the treatment of cognitive failure |
| 09/22/2004 | EP1458364A1 Pharmaceutical compositions comprising metformine and glibenclamide for the treatment of type-ii diabetes mellitus |
| 09/22/2004 | EP1458355A2 Aqueous based pharmaceutical formulations of water-soluble prodrugs of propofol |
| 09/22/2004 | EP1458349A1 Composition comprising at least an oxazolin for inhibiting langerhans cell migration, and uses thereof |
| 09/22/2004 | EP1458347A2 Composition comprising at least an alkanolamide for inhibiting langerhans cell migration, and uses thereof |
| 09/22/2004 | EP1458234A1 Disruption of the prostaglandin e synthase 2 gene |
| 09/22/2004 | EP1268389B1 Halogenated triphenylethylene derivatives as selective estrogen receptor modulators |
| 09/22/2004 | EP1261335A4 Brain, spinal and nerve injury treatment |
| 09/22/2004 | EP1259598B1 Stimulation of cartilage growth with agonists of the non-proteolytically activated thrombin receptor |
| 09/22/2004 | EP1223916B1 Neutral-cationic lipid for nucleic acid and drug delivery |
| 09/22/2004 | EP1222187B1 Heterocyclic compounds useful as inhibitors of tyrosine kinases |
| 09/22/2004 | EP1192165B1 Substituted heterocycle fused gamma-carbolines |
| 09/22/2004 | EP1189904B1 Substituted heterocycle fused gamma-carbolines |
| 09/22/2004 | EP1187629B1 Adjuvant composition comprising saponin and an immunostimulatory oligonucleotide |
| 09/22/2004 | EP1169320B1 Farnesyl transferase inhibitors having a pyrrole structure and process for preparation thereof |
| 09/22/2004 | EP1157989B1 Fluorides of 4-substituted piperidine derivatives |
| 09/22/2004 | EP1153014B1 Beta-alanine derivatives |
| 09/22/2004 | EP1146874B1 Vitronectin receptor antagonist |
| 09/22/2004 | EP1144402B1 Substituted oximes and hydrazones as neurokinin antagonists |
| 09/22/2004 | EP1141251A4 Compounds, methods of screening and methods of treatment for central and peripheral nervous system disorders |
| 09/22/2004 | EP1140981B1 Tripeptide compounds useful as selective inhibitors of aminopeptidase a and corresponding pharmaceutical compositions |
| 09/22/2004 | EP1135161B1 Chemotherapeutic composition and method |
| 09/22/2004 | EP1124820B1 Lipoic acid derivatives and their use in treatment of disease |
| 09/22/2004 | EP1124801B1 Piperidine and pyrrolidine derivatives comprising a nitric oxide donor for treating stress |
| 09/22/2004 | EP1100503B1 Non-imidazole alkylamines as histamine h 3?-receptor ligands and their therapeutic applications |
| 09/22/2004 | EP1077950B1 Novel diphenyl-substituted 6-ring-heterocycles, methods for producing them and their use as medicaments |
| 09/22/2004 | EP1054869B1 3,4-dihydroquinoline derivatives as nitrogen monoxide synthase (nos) inhibitors |
| 09/22/2004 | EP1040112B1 Imidazonaphthyridines and their use in inducing cytokine biosynthesis |
| 09/22/2004 | EP1005539B1 Ikk-alpha proteins, nucleic acids and methods |
| 09/22/2004 | EP1000062B1 Tricyclic vasopressin agonists |
| 09/22/2004 | EP0879231B1 Dihydrobenzofuran and related compounds useful as anti-inflammatory agents |
| 09/22/2004 | EP0830347B1 Novel substituted piperazine derivatives having tachykinin receptor antagonists activity |
| 09/22/2004 | EP0623133B1 Substituted amino alkyl compounds |
| 09/22/2004 | CN1531591A Method for introducing nucleic acids and other biologially active molecules into nucleus of higher exkaryotic cells by means of electrical current |
| 09/22/2004 | CN1531552A Chimeric proteins for cell targeting and apoptosis induction and methods of using same |
| 09/22/2004 | CN1531550A Heterocarpine, human GHRH-binding protein |
| 09/22/2004 | CN1531549A Pharmaceutical use for secreted bacterial effector proteins |
| 09/22/2004 | CN1531547A Hepatitis C tripeptide inhibitors |
| 09/22/2004 | CN1531546A Peptide compounds |
| 09/22/2004 | CN1531538A 4-amino-5-phenyl-7-cyclobutyl-pyrrolo (2,3-D) pyrimidie derivatives |
| 09/22/2004 | CN1531536A Process for preparation of pyrazolo[4,3-D] pyrimidine derivative |
| 09/22/2004 | CN1531535A Phenylacetamido-thiazole derivatives, process for their preparation and their use as antitumor agents |
| 09/22/2004 | CN1531533A Crystalline form of omeprazole |
| 09/22/2004 | CN1531531A Novel arylsusfonamide compounds for treatment of obesity, type II diabetes and CNS-disorders |
| 09/22/2004 | CN1531529A 4-(benzylidenje-amino)-3-(methylsulfanyl)-4H-(1,2,4) triazin-5-one derivatives having PDE-IV inhibiting and TNF-antagonistic effect for treatment of cardiac diseases and allergies |
| 09/22/2004 | CN1531528A Dibenzocycloheptene compound |
| 09/22/2004 | CN1531527A Carbazole derivatives and their use as neuropeptide Y5 receptor ligands |
| 09/22/2004 | CN1531525A Organic compounds |
| 09/22/2004 | CN1531444A Synthetic catalyst for selective cleavage of protein and method for selective cleavage of protein using same |
| 09/22/2004 | CN1531441A Pharmaceutical compositinos which inhibit vascular proliferation and method of use thereof |
| 09/22/2004 | CN1531440A Pharmaceutical composition for preventing or treating TH1 and TH2 cell related diseases by modulating TH/TH2 ratio |
| 09/22/2004 | CN1531437A Use of non-digestible polymeric foams to sequester ingested materials thereby inhibiting their absorption by body |
| 09/22/2004 | CN1531435A Methods for inhibiting angiogenesis |
| 09/22/2004 | CN1531431A Prevention of addiction in pain management |
| 09/22/2004 | CN1531430A Local used composition containing antifungal agent |
| 09/22/2004 | CN1531429A Medicament, containing effector of glutathione metabolism together with alpha-lipoic acid for use in kidney replacement therapy |
| 09/22/2004 | CN1531425A Urea derivatives as integrin alpha 4 antagonists |
| 09/22/2004 | CN1530366A Sulphonic acid amide for regulating bast peptide activity and derivative thereof |
| 09/22/2004 | CN1530110A Naloxone freeze-drying powder injection and preparing technology thereof |
| 09/22/2004 | CN1530107A Insulin resistance treatment by growth hormone secretory hormone |
| 09/22/2004 | CN1530106A Medicine composition for treating diabet mellitus |
| 09/22/2004 | CN1530105A Medicine composition for treating diabets and mellitus |
| 09/22/2004 | CN1530102A Medical preparation containing alpha-thioctan, ambroxol and/or ACE inhibiting agent and its use in treating neurodegenerative diseases |
| 09/22/2004 | CN1167709C N-pyrazole AZA receptor agonists |
| 09/22/2004 | CN1167703C Azabicyclic carbamates and their use as alpha-7 nicotinic acetyl choline receptor agonists |
| 09/22/2004 | CN1167698C New N-triazolyl methyl piperazine derivative using as neurokinin receptor antagonistic agent |
| 09/22/2004 | CN1167692C Aminothiazole derivatives and their use as CRF receptor ligands |
| 09/22/2004 | CN1167691C Substituted eenzylthiazolidie-2,4-dione derivatives |
| 09/22/2004 | CN1167687C Arylpyridazinones as prostaglandin endoperoxide H synthase biosynthesis inhibitors |
| 09/22/2004 | CN1167682C Muscarinic antagonists |
| 09/22/2004 | CN1167681C Condensed indoline derivatives and their use as 5HT, in particular 5HT2 receptor ligands |
| 09/22/2004 | CN1167670C Aryl carboxylic acid and tetrazole derivant |
| 09/22/2004 | CN1167667C Aminobenzophenones as inhibitors IL-1 beta and TNF-alpha |
| 09/22/2004 | CN1167466C Oral medicinal preparation |
| 09/22/2004 | CN1167426C Preparation of zymolite of blue scad to improve function of brain cells |
| 09/22/2004 | CN1167423C Means for treating radiation injuries |
| 09/22/2004 | CN1167420C Azabanzimidazole-based compounds for modulating serine/threonine protein kinase function |
| 09/22/2004 | CN1167416C Use of glucose uptake enhancer for reducing post-ischemic injury of heart |
| 09/22/2004 | CN1167409C Cosmetic compositions containing mulberry extract and retinoids |
| 09/21/2004 | US6795776 Crystallographic structure of the androgen receptor ligand binding domain |
| 09/21/2004 | US6794544 Method for the preparation of tetrahydrobenzothiepines |
| 09/21/2004 | US6794541 Thiourea and urea liquid-phase combinatorial libraries: synthesis and apoptosis induction |
| 09/21/2004 | US6794512 Antiinflammatory agents; cyclooxygenase inhbitors; anticancer agents; autoimmune disease |
| 09/21/2004 | US6794405 Alicyclic imidazoles as H3 agents |
| 09/21/2004 | US6794404 Viral polymerase inhibitors |
| 09/21/2004 | US6794402 Bicyclic cyclohexylamines and their use as NMDA receptor antagonists |
| 09/21/2004 | US6794399 Beta-adrenoreceptor and calcium channel blocking agent; induced vasorelaxing effect |
| 09/21/2004 | US6794397 Substituted nicotinamides and analogs as activators of caspases and inducers of apoptosis and the use thereof |
| 09/21/2004 | US6794395 Substituted indolinones, their manufacture and their use as medicaments |
| 09/21/2004 | US6794391 Inhibitors of phosphodiesterase (pde) isoenzymes; useful for treatment of respiratory disorders such as asthma. |
| 09/21/2004 | US6794386 β-amino acid compounds as integrin antagonists |
| 09/21/2004 | US6794384 Hydroxylation activated drug release |
| 09/21/2004 | US6794383 Heart muscular cell apoptosis inhibitors and remedies/preventives for heart diseases |
| 09/21/2004 | US6794380 Amide derivatives |
| 09/21/2004 | US6794377 Ortho, ortho-substituted nitrogen-containing bisaryl compounds, useful for the treatment and prophylaxis of atrial arrhymias, e.g. atrail fibrillation or atrial flutters |
| 09/21/2004 | US6794373 Contraceptive methods using benzimidazolones |
| 09/21/2004 | US6794363 Isolated amyloid inhibitor protein (APIP) and compositions thereof |
| 09/21/2004 | US6794178 Nucleotide sequences coding transport protein for us in the treatment and diagnosis of cancer, arthritis, vision defects and skin dsorders |
| 09/21/2004 | US6794169 Enzymatic polypeptide for use in the biosynthesis of glycans |